Infectious Diseases – Products

AMSBIO now offers high-purity, lyophilized exosome standards to enhance reproducibility in extracellular vesicle research.

Bio-Rad has introduced four new Droplet Digital PCR platforms, including the QX Continuum™ and QX700™ series. These additions enhance Bio-Rad’s ddPCR offerings with simplified workflows, advanced multiplexing and high throughput.

SMi Systems earns ISO 13485 certification for high-quality design of IVD instruments aiding disease detection.

Integrated DNA Technologies is expanding its infectious disease portfolio with new solutions to enhance worldwide research efforts in monitoring infectious disease dynamics, supporting surveillance and accelerating biomarker discovery.

Diasorin’s LIAISON PLEX® Gram-Positive Blood Culture Assay receives FDA clearance, aiding rapid, targeted infection diagnosis.

DEBRA Research and Dermaliq partner to advance cutaneous drug delivery for improved wound healing and therapies in EB.

Revvity launches the IDS i20™ platform, automating chemiluminescence immunoassays for multiple diagnostic specialties, increasing throughput and flexibility.

Creative Peptides has enhanced its peptide library construction and screening services, incorporating advanced technologies like high-throughput screening, phage, and mRNA display to speed up drug discovery.

A new study highlights IsoPSA’s ability to identify low-risk prostate cancer patients who can avoid unnecessary interventions. The test also helps monitor high-risk patients more closely.

Bruker expands its microbiology solutions with new NGS-based tools for hospital infection tracking and epidemiology, in collaboration with Ridom GmbH.